Skip to content

The effect of a traditional Chinese medicine prescription on liver regeneration and gastrointestinal function after partial hepatectomy: a prospective randomized controlled study

The effect of a traditional Chinese medicine prescription on liver regeneration and gastrointestinal function after partial hepatectomy: a prospective randomized controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048655
Enrollment
Unknown
Registered
2021-07-12
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver diseases

Interventions

Sponsors

Binzhou Medical University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who are confirmed by imaging examination and require partial hepatectomy; 2. The patient can tolerate the resected liver volume; 3. Aged 18-75 years old, male or female; 4. The patients voluntarily joined the study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with malnutrition (BMI<18.5kg/m2); 2. Congestive heart failure, uncontrollable arrhythmia, myocardial infarction, unstable angina pectoris, stroke or transient ischemic attack within 6 months; 3. Patients who cannot comply with the trial protocol or cannot cooperate with follow-up; 4. The researchers believe that it is not suitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Liver volume;Intestinal exhaust time;intestinal secretory IgA;

Secondary

MeasureTime frame
Alanine aminotransferase;Aspartate aminotransferase;Bilirubin;

Countries

China

Contacts

Public ContactChen Qiangpu

Binzhou Medical University Hospital

drcqp_med@163.com+86 13854348678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026